Novel Technologies for Vaccine Development by Igor S Lukashevich, Haval Shirwan

By Igor S Lukashevich, Haval Shirwan

This e-book provides an in depth evaluate of the improvement of latest viral vector-based vaccines prior to discussing significant functions: preventive vaccines for infectious illnesses and healing melanoma vaccines. Viral vector-based vaccines carry a superb capability for improvement into winning pharmaceutical items and a number of other examples on the complicated pre-clinical or scientific level are awarded. however, the main efforts have been all for novel and intensely leading edge applied sciences for brand new new release of vector-based vaccines. additionally, particular subject matters comparable to supply and adjuvant and defense concepts for cell-mediated-based vaccines are offered. Given its scope, the publication is a “must learn” for all these keen on vaccine improvement, either in academia and commercial vaccine development.

Show description

Read Online or Download Novel Technologies for Vaccine Development PDF

Best immunology books

Human Antibody Therapeutics For Viral Disease (Current Topics in Microbiology and Immunology)

Even supposing the software of human antibodies as clinical therapeutics for melanoma and immune ailments has been well-established, it is just starting to be discovered for the therapy of viral infectious ailments. Polyclonal immunoglobulins have lengthy been used for a few viral illnesses, yet they've got constrained efficiency and illness scope.

The Tumor Immunoenvironment

Research of multidirectional immunological responses on the tumor web site permits forming a brand new inspiration of The Tumor Immunoenvironment, that is brought and mentioned within the current publication with a specific specialise in the position of immune cells in controlling the tumor microenvironment at diverse phases of melanoma improvement.

Antibodies in cell biology

Antibodies in telephone Biology makes a speciality of a brand new iteration of protocols aimed toward the mobilephone biologist. This laboratory guide positive factors structures and strategies which are specifically proper for contemporary difficulties. The contributing authors were conscientiously selected for his or her particular services, and feature supplied designated protocols, recipes, and troubleshooting courses in each one bankruptcy.

Additional info for Novel Technologies for Vaccine Development

Sample text

This hurdle could be overcome by using cell lines that express the respective wild-type protein, resulting in efficient vaccine virus growth in such helper cells. Cell lines expressing the viral polymerases (Ozawa et al. 2013), the PB2 polymerase subunit (Ozawa et al. 2011; Victor et al. 2012), NS1/NS2 (Portela et al. 1986), or the M2 protein (Hatta et al. 2011; Octaviani et al. 2010; Watanabe et al. 2009) have been established to date. The M1 matrix protein is the major structural component of the virus.

J Infect Dis 199:711–716 Keitel WA, Atmar RL (2009) Vaccines for pandemic influenza: summary of recent clinical trials. Curr Top Microbiol Immunol 333:431–451 Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bosman A (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587–593 Krammer F, Pica N, Hai R, Margine I, Palese P (2013) Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies.

Curr Top Microbiol Immunol 333:109–132 China Mission Report (2013) China—WHO Joint Mission on Human Infection with Avian Influenza A(H7N9) Virus. pdf Cobbin JC, Verity EE, Gilbertson BP, Rockman SP, Brown LE (2013) The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus. J Virol 87:5577–5585 Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, de Boer-Luijtze EA, van Zoelen-Bos DJ, Rigter A, Rottier PJ, Moormann RJ, de Haan CA (2012) Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.

Download PDF sample

Rated 4.62 of 5 – based on 42 votes